Anaplastic lymphoma kinase modulators and methods of use

Details for Australian Patent Application No. 2011202643 (hide)

Owner Exelixis, Inc.

Inventors Anand, Neel Kumar; Blazey, Charles M.; Bowles, Owen Joseph; Bussenius, Joerg; Costanzo, Simona; Curtis, Jeffry Kimo; Dubenko, Larisa; Kennedy, Abigail R.; Khoury, Richard G.; Kim, Angie I.; Manalo, Jean-Claire L.; Peto, Csaba J.; Rice, Kenneth D.; Tsang, Tsze H.

Agent Davies Collison Cave

Pub. Number AU-A-2011202643

Parent 2004259012

Filing date 3 June 2011

Wipo publication date 23 June 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202643

23 June 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202644-Expressed joint facade system

2011202642-Garment Backpack